Last reviewed · How we verify
NCT06749327
Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health
NA trial testing High UPF, high hPDI diet in Cardiometabolic Risk Factors in 330 participants. Not yet recruiting.
1 March 2027
Quick facts
| Lead sponsor | Queen's University, Belfast |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 330 |
| Start date | 1 October 2025 |
| Primary completion | 1 March 2027 |
| Estimated completion | 1 March 2029 |
| Sites | 2 locations across United Kingdom, Ireland |
Drugs / interventions tested
- High UPF, high hPDI diet
- Low UPF, high hPDI diet
Conditions studied
- Cardiometabolic Risk Factors — all drugs for Cardiometabolic Risk Factors →
Sponsor
Queen's University, Belfast
Who can join
Adults 18 to 65, any sex, with Cardiometabolic Risk Factors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Controversy remains around the role of ultra-processed food (UPF) consumption and health outcomes. A key question that remains to be answered is: when diet quality is the same, does food processing itself have any independent health effects? The current application aims to isolate the health effects of food processing from those of diet quality through the conduct of a dietary intervention study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06749327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiometabolic Risk Factors
Currently open trials in the same condition.
- NCT07322237 — DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis · Phase 4 · recruiting
- NCT07363616 — Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight · NA · recruiting
- NCT07053657 — Effect of Vitamin D on Cardiovascular Metabolic Risk in Overweight/Obesity Adolescents in China · NA · recruiting
- NCT07513168 — Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults · Phase 4 · recruiting
- NCT06775132 — Associations Between Dietary Intake and Cardiometabolic and Gut Microbiota Outcomes · recruiting
Other Queen's University, Belfast trials
Trials by the same sponsor.
- NCT07373041 — Heart Failure Carer Support Programme: Implementation Testing in the UK. · NA · not yet recruiting
- NCT07482839 — Feasibility Study of a Compassionate Mindful Resilience (CMR) Intervention to Improve Mental Health Well-being Outcomes · NA · not yet recruiting
- NCT07333924 — Randomised Study Within a Review (SWAR) to Compare Communication of the Findings of Systematic Reviews to the Public by · Phase 3 · completed
- NCT06896799 — Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM) · NA · recruiting
- NCT07107087 — A Cluster Randomised Controlled Trial of a Multimodal Integrated Intervention for Kidney Cachexia · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06749327 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen's University, Belfast
- Last refreshed: 3 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06749327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing